This Viewpoint discusses the use of glucagon-like peptide-1 (GLP-1) receptor agonists as a strategy to manage psychotropic-induced weight gain.
This Viewpoint discusses the use of glucagon-like peptide-1 (GLP-1) receptor agonists as a strategy to manage psychotropic-induced weight gain.